Abstract
In this weeks issue of Eurosurveillance, Zambon and colleagues describe the first findings of the European Union-funded European Surveillance Network for Vigilance Against Viral Resistance (VIRGIL) of some seasonal influenza viral isolates resistant to the antiviral drug oseltamivir in Europe.
Publication types
-
Editorial
-
Introductory Journal Article
MeSH terms
-
Antiviral Agents / pharmacology*
-
Drug Resistance, Viral*
-
Europe
-
Humans
-
Influenza A Virus, H1N1 Subtype / drug effects*
-
Influenza A Virus, H1N1 Subtype / pathogenicity
-
Influenza, Human / drug therapy
-
Influenza, Human / mortality
-
Influenza, Human / virology
-
Oseltamivir / pharmacology*
-
Seasons
-
Virulence
-
World Health Organization
Substances
-
Antiviral Agents
-
Oseltamivir